IQVia
Healthcare data and life sciences platform
About
IQVIA was formed in 2016 from the merger of IMS Health (founded 1954) and Quintiles (founded 1982), two dominant players in healthcare data and clinical research outsourcing respectively. The combined company provides pharmaceutical, biotech, and medical device companies with access to 1.2 billion non-identified patient records, real-world evidence analytics, clinical trial operations, and commercial analytics for drug launch and market access decisions. IQVIA serves every major global pharma and biotech company and is publicly traded on the NYSE. In 2026 it launched IQVIA.ai, a unified agentic AI platform built with NVIDIA.
Products
-
IQVIA AI
— Leverage advanced AI technology for data-driven insights and streamlined research in life sciences.
Customer sectors: life sciences, pharmaceutical manufacturers, research scientists
-
Real World Evidence Solutions
— Generate and disseminate evidence using real-world data to support clinical, regulatory, and commercial decisions.
Customer sectors: pharmaceutical manufacturers, regulatory affairs, health economics
-
Therapeutic and Specialty Centers of Excellence
— Provide scientific expertise and clinical trial experience to accelerate new therapy development.
Customer sectors: clinical researchers, pharmaceutical manufacturers, therapeutic specialists
-
Global Laboratories
— Offer specialty and central lab services with scientific rigor in biomarkers and drug discovery.
Customer sectors: clinical researchers, pharmaceutical manufacturers, biotechnology firms
-
Commercialization Solutions
— Enhance commercial effectiveness with data-driven insights, HCP and patient engagement, and brand strategy support.
Customer sectors: pharmaceutical manufacturers, commercial teams, brand managers
Market research & competitive positioning
Source-backed TAM / SAM / SOM sizing, displacement analysis, and an interactive peer positioning map for IQVia — available to members.
Related Companies
Other startups in Data Management Platforms
